Distinct air pollutants show varying links to lung cancer subtypes and survival rates
A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer.
Jan 21, 2026
0
11
Neoplasms: News and Research on Bronchial Neoplasms
MeSH tree: C04.588.894.797.520.109
A new strategy to beat lung cancer: Chemists develop first-in-class inhibitor targeting a key epigenetic regulator
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a first-in-class chemical inhibitor that precisely and selectively targets the ATAC complex, a critical cellular ...
Jan 19, 2026
0
45
Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting ...
Jan 14, 2026
0
11
ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about sustainability, prevention ...
Jan 12, 2026
0
16
Liquid biopsy advances could yield new tool for detecting lung cancer mutations
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
Jan 7, 2026
0
21
Inflammation fuels one of the most aggressive forms of lung cancer
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to chemotherapy. However, patients ...
Dec 23, 2025
0
44
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and grow more slowly than ...
Dec 17, 2025
0
16
Study shows IL-36 gamma 'armored' CAR T cells can eradicate solid tumors
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric antigen receptor (CAR) T-cell therapy in solid-tumor cancers, resulting in their eradication. Led ...
Dec 12, 2025
0
48
Higher glycemic index linked to higher lung cancer risk
In a study appearing in The Annals of Family Medicine, researchers examined whether people who follow higher-GI or higher-GL diets have different risks of developing lung cancer. They used data from 101,732 adults in the ...
Nov 25, 2025
0
15
New study highlights key findings on lung cancer surveillance rates
Despite recommendations for posttreatment surveillance in lung cancer patients, there is wide variability in the follow-up care that lung cancer patients receive. A recent study, led by senior author Leah Backhus, MD, MPH, ...
Nov 21, 2025
0
8
